In this handout photo released by the University of Oxford, a volunteer participates in a vaccine trial in Oxford, England on July 7. Canada's federal government announced Monday it had signed agreements with two U.S. drug companies to secure up to 114 million doses of potential COVID-19 vaccines under development. (University of Oxford/Associated Press)

Ottawa secures up to 114 million doses of potential COVID-19 vaccines

Canada’s federal government said Monday it had signed agreements with two U.S. drug companies to secure up to 114 million doses of potential COVID-19 vaccines under development.

Deals are now in place for Canada to get access to vaccines being tested by both Johnson & Johnson and Novavax.

Earlier this month, Ottawa signed similar deals with Pfizer and Moderna.

The vaccines are still in either Phase 2 or 3 clinical trials and won’t be purchased unless they are deemed safe and effective by Health Canada.

Novavax, a Maryland-based biotechnology company, announced in a press release Monday that it has struck a deal to produce 76 million doses of a vaccine that it is working on for the Canadian government, should the vaccine ever get Health Canada approval.

Later in the day, Ottawa announced it has signed a separate deal with a subsidiary of New Jersey-based drug conglomerate Johnson & Johnson to secure up to 38 million doses of the company’s potential vaccine, which is completely different from Novavax’s.

The vaccines are two of dozens in development around the world, each of which targets the virus that causes COVID-19 in a different way.

Prime Minister Justin Trudeau said Monday, the vaccines all show promising results and Canada is signing multiple deals to be sure when a vaccine is approved Canadians can get access to it.

COVID-19 IN CANADA
The latest numbers of confirmed COVID-19 cases in Canada as of 4:50 p.m. EDT on Aug. 31, 2020: There are 128,228 confirmed cases in Canada. — Quebec: 62,492 confirmed (including 5,760 deaths, 55,353 resolved) — Ontario: 42,309 confirmed (including 2,811 deaths, 38,277 resolved) — Alberta: 13,476 confirmed (including 237 deaths, 12,054 resolved) — British Columbia: 5,496 confirmed (including 204 deaths, 4,310 resolved) — Saskatchewan: 1,619 confirmed (including 24 deaths, 1,561 resolved) — Manitoba: 1,214 confirmed (including 14 deaths, 731 resolved) — Nova Scotia: 1,085 confirmed (including 65 deaths, 1,013 resolved) — Newfoundland and Labrador: 269 confirmed (including 3 deaths, 265 resolved) — New Brunswick: 191 confirmed (including 2 deaths, 185 resolved) — Prince Edward Island: 44 confirmed (including 41 resolved) — Yukon: 15 confirmed (including 15 resolved) — Repatriated Canadians: 13 confirmed (including 13 resolved) — Northwest Territories: 5 confirmed (including 5 resolved) — Nunavut: No confirmed cases — Total: 128,228 (0 presumptive, 128,228 confirmed including 9,120 deaths, 113,823 resolved) (The Canadian Press)

COVID-19 has now killed more than 846,000 people around the world since the start of this year, including, 9,120 in Canada.

The agreement with Novovax “will give Canadians access to a promising COVID-19 vaccine candidate,” Anita Anand, Canada’s minister of public services and procurement, in a news release on Monday.

Health Minister Pattorters a vaccine for COVID-19 will be more effective if large numbers of people get it.

WATCH: Federal Health Minister Patty Hajdu answers a question about how many Canadians may need to be vaccinated.

Novavax said Monday the vaccine, should it work and be safe, would be available to Canadians as early as the second quarter of next year.

Novavax has signed similar deals with the United Kingdom, India, the Czech Republic, South Africa and Japan to supply doses of the potential vaccine.

Financial terms of the deal were not disclosed.

With files from CBC News, The Canadian Press

Categories: Health, International, Internet, Science & Technology, Society
Tags: , , , , ,

Do you want to report an error or a typo? Click here!

For reasons beyond our control, and for an undetermined period of time, our comment section is now closed. However, our social networks remain open to your contributions.